Thus, our data coincides with the current understanding of metabolic alterations in pseudohypoxic signaling in gliomas and provides an oncometabolite-mediated mechanism that parallels the HIFα stabilization known to be present in IDH-mutant gliomas. Here, IDH1 is linked to central nervous system cancer.